$RGEN · REPLIGEN CORP SEC Filings
Position Tracker tracks 4 SEC EDGAR filings for REPLIGEN CORP ($RGEN) from October 27, 2026 through November 6, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 3 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$RGEN 8-K — REPLIGEN CORP
Repligen refinanced higher-coupon 2028 debt into 0.25% notes while raising $458.6M cash, but the deal adds up to 5.3M shares of potential dilution.
$RGEN 10-Q — REPLIGEN CORP
A $41.2M impairment charge turning solid revenue growth into a deep net loss, paired with a transformative $1.9B acquisition on deck, makes this a pivotal quarter for Repligen.
$RGEN 8-K — REPLIGEN CORP
A $1B convertible note transaction that simultaneously refinances near-term debt at a sharply lower coupon, raises fresh capital for M&A, and includes a concurrent buyback — a m…
$RGEN 8-K — REPLIGEN CORP
A $41.2M impairment charge cratered GAAP earnings even as organic growth accelerated to 12.5% and full-year guidance was raised — a classic "noisy quarter" that tests whether in…